Latest stories on ANIX
H.C. Wainwright lowers Anixa Biosciences stock price target to $6
Investing.com Analyst Ratings34 · bearishanalyst
Anixa Biosciences price target lowered to $6 from $7 at H.C. Wainwright
The Fly34 · bearishanalyst
Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
PR Newswire63 · neutralproduct/pr
Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
PR Newswire56 · neutralgeneral
Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
PR Newswire56 · neutralproduct/pr
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
PR Newswire56 · neutralproduct/pr
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan67 · bullishproduct/pr
Anixa Biosciences Expands Global Patent Portfolio with Australian Patent Acceptance for Breast Cancer Vaccine Technology
PR Newswire63 · neutralproduct/pr
Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
PR Newswire67 · bullishproduct/pr